Filing Flows › Teva Pharmaceutical Industries (TEVA) › Net income
Teva Pharmaceutical Industries (TEVA) net income by quarter
Teva Pharmaceutical Industries' net income was $234M in Q3 2026 (third quarter 2026), -37% from Q1 2026. Over the last 6 quarters it ranged from $214M (Q1 2025) to $480M (Q4 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $234M | -37% | -46% |
| Q1 2026 | $369M | -23% | +72% |
| Q4 2025 | $480M | +11% | — |
| Q3 2025 | $433M | +54% | — |
| Q2 2025 | $282M | +32% | — |
| Q1 2025 | $214M | — | — |
Q3 2026 at a glance
Teva Pharmaceutical Industries, Q3 2026: revenue $4.4B (-2% year over year), operating margin 16.2%, net earnings $234M, operating cash flow $241M. The chart follows the revenue to costs, profit and cash.
Questions
What is Teva Pharmaceutical Industries' net income?
Teva Pharmaceutical Industries' net income was $234M in Q3 2026 (third quarter 2026), -37% from Q1 2026.
How has Teva Pharmaceutical Industries' net income changed?
Over the last 6 quarters it ranged from $214M (Q1 2025) to $480M (Q4 2025).
Q3 2026 results → · How Teva Pharmaceutical Industries makes money →